The oligomer modulator anle138b inhibits disease progression in a Parkinson 
mouse model even with treatment started after disease onset.

Levin, J.; Schmidt, F.; Boehm, C.; Prix, C.; Bötzel, K.; Ryazanov, S.; Leonov, A.; Griesinger, C.; Giese, A.

doi:10.1007/s00401-014-1265-3

Item

ITEM ACTIONSEXPORT

Add to Basket

Please note that a newer version of this item is available:
https://pure.mpg.de/pubman/item/item_2029603_4

DetailsSummary

Released

Journal Article

The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset.

MPS-Authors

/persons/resource/persons45923

Ryazanov, S.
Department of NMR Based Structural Biology, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons15438

Leonov, A.
Department of NMR Based Structural Biology, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons15147

Griesinger, C.
Department of NMR Based Structural Biology, MPI for biophysical chemistry, Max Planck Society;

External Resource

http://link.springer.com/content/pdf/10.1007%2Fs00401-014-1265-3.pdf
(Publisher version)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

2029603.pdf
(Publisher version), 189KB

Supplementary Material (public)

There is no public supplementary material available

Citation

Levin, J., Schmidt, F., Boehm, C., Prix, C., Bötzel, K., Ryazanov, S., et al. (2014). The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset. Acta Neuropathologica, 127(5), 779-780. doi:10.1007/s00401-014-1265-3.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0019-8C7F-0

Abstract

There is no abstract available